Real-world outcome of rTMS treatment for depression within the Japanese public health insurance system: Registry data from Kansai TMS network

Imazu, Shinichi; Ikeda, Shunichiro; Toi, Yuuki; Sano, Shoko; Kanazawa, Tetsufumi; Shinosaki, Kazuhiro; Tsukuda, Banri; Kita, Akira; Kuroda, Kenji; Takahashi, Shun

doi:https://doi.org/10.1016/j.ajp.2024.104082

Real-world outcome of rTMS treatment for depression within the Japanese public health insurance system: Registry data from Kansai TMS network

Imazu, Shinichi; Ikeda, Shunichiro; Toi, Yuuki et al.

Asian Journal of Psychiatry, 2024, 97, 104082

アクセス数:959件（2025-10-28 01:26 集計）

固定URL: https://hdl.handle.net/11094/97171

閲覧可能ファイル

ファイル	フォーマット	利用条件	サイズ	閲覧回数	利用開始日	説明	information
AsianJPsychiatry_97_104082	pdf	なし	493 KB	168	2024.07.16

Creative Commons : 表示 - 非営利 - 改変禁止

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

タイトル	Real-world outcome of rTMS treatment for depression within the Japanese public health insurance system: Registry data from Kansai TMS network
著者	NRID 1000070896638 1000070896638 著者名 Imazu, Shinichi
	NRID 1000040772231 1000040772231 著者名 Ikeda, Shunichiro
	著者名 Toi, Yuuki
	著者名 Sano, Shoko
	NRID 1000020534100 1000020534100 著者名 Kanazawa, Tetsufumi
	NRID 1000040215984 1000040215984 著者名 Shinosaki, Kazuhiro
	著者名 Tsukuda, Banri
	NRID 1000020735914 1000020735914 著者名 Kita, Akira
	NRID 1000020170128 1000020170128 著者名 Kuroda, Kenji
	NRID 1000010508021 1000010508021 ORCID 0000-0002-9049-4694 0000-0002-9049-4694 researchmap permalink shun_takahashi shun_takahashi 著者名 Takahashi, Shun
キーワード等	depression
	efficacy
	registry
	repetitive transcranial magnetic stimulation
内容	Imazu S., Ikeda S., Toi Y., et al. Real-world outcome of rTMS treatment for depression within the Japanese public health insurance system: Registry data from Kansai TMS network. Asian Journal of Psychiatry 97, 104082 (2024); https://doi.org/10.1016/j.ajp.2024.104082.
抄録	This study registered consecutive cases to elucidate the efficacy of rTMS treatment for depression within the Japanese public health insurance system. Of the 102 patients with depression who received rTMS over the left dorsolateral prefrontal cortex, 44 (43.1 %) patients reached remission and 14 (13.7 %) patients did not reach remission but responded to treatment. No serious adverse events occurred. Low baseline HAMD-17 score was associated with remission after rTMS treatment. Favorable outcomes of rTMS treatment were shown in this cohort within the Japanese public insurance system. Our results provide insights into rTMS treatment for depression in real-world clinical setting.
出版者	Elsevier B.V.
収録物名	Asian Journal of Psychiatry
巻(号)	97
ページ	104082
刊行年月	2024-07-01
言語	英語
ハンドルURL	https://hdl.handle.net/11094/97171
PISSN	18762018
eISSN	18762026
関連情報 (isIdenticalTo)	DOI (出版社版) https://doi.org/10.1016/j.ajp.2024.104082
アクセス権	open access
権利情報	This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
出版タイプ	Version of Record
カテゴリ	学術雑誌論文 Journal Article

資源タイプ	学術雑誌論文
ローカル資源タイプ	学術雑誌論文
DCTERMS.bibliographicCitation	Asian Journal of Psychiatry. 2024, 97, p. 104082
DC.title	Real-world outcome of rTMS treatment for depression within the Japanese public health insurance system: Registry data from Kansai TMS network
DC.creator	Imazu, Shinichi
	Ikeda, Shunichiro
	Toi, Yuuki
	Sano, Shoko
	Kanazawa, Tetsufumi
	Shinosaki, Kazuhiro
	Tsukuda, Banri
	Kita, Akira
	Kuroda, Kenji
	Takahashi, Shun
DC.publisher	Elsevier B.V.
DC.language' scheme='DCTERMS.RFC1766	英語
DCTERMS.issued' scheme='DCTERMS.W3CDTF	2024-07-01
DC.identifier	https://doi.org/10.1016/j.ajp.2024.104082
DC.subject	depression
	efficacy
	registry
	repetitive transcranial magnetic stimulation
DC.description	Imazu S., Ikeda S., Toi Y., et al. Real-world outcome of rTMS treatment for depression within the Japanese public health insurance system: Registry data from Kansai TMS network. Asian Journal of Psychiatry 97, 104082 (2024); https://doi.org/10.1016/j.ajp.2024.104082.
DCTERMS.abstract	This study registered consecutive cases to elucidate the efficacy of rTMS treatment for depression within the Japanese public health insurance system. Of the 102 patients with depression who received rTMS over the left dorsolateral prefrontal cortex, 44 (43.1 %) patients reached remission and 14 (13.7 %) patients did not reach remission but responded to treatment. No serious adverse events occurred. Low baseline HAMD-17 score was associated with remission after rTMS treatment. Favorable outcomes of rTMS treatment were shown in this cohort within the Japanese public insurance system. Our results provide insights into rTMS treatment for depression in real-world clinical setting.
DC.rights	This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
DC.format	97171
citation_title	Real-world outcome of rTMS treatment for depression within the Japanese public health insurance system: Registry data from Kansai TMS network
citation_author	Imazu, Shinichi
	Ikeda, Shunichiro
	Toi, Yuuki
	Sano, Shoko
	Kanazawa, Tetsufumi
	Shinosaki, Kazuhiro
	Tsukuda, Banri
	Kita, Akira
	Kuroda, Kenji
	Takahashi, Shun
citation_publisher	Elsevier B.V.
citation_language	英語
citation_date	2024-07-01
citation_journal_title	Asian Journal of Psychiatry
citation_volume	97
citation_firstpage	104082
citation_doi	https://doi.org/10.1016/j.ajp.2024.104082
citation_public_url	https://hdl.handle.net/11094/97171

Real-world outcome of rTMS treatment for depression within the Japanese public health insurance system: Registry data from Kansai TMS network

閲覧可能ファイル

論文情報

論文詳細を表示